Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential

被引:59
作者
Fan, Dahua [1 ,2 ,3 ]
Liu, Liping [4 ]
Wu, Zhengzhi [1 ,3 ]
Cao, Meiqun [3 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen, Guangdong, Peoples R China
[2] Jinan Univ, Shcool Med, Chinese & Wsetern Integrat Med, Guangzhou, Guangdong, Peoples R China
[3] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[4] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Hepatobiliary & Pancreas Surg, Shenzhen, Guangdong, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Neurodegenerative diseases; berberine; neuroprotection; oxidative stress; neuroinflammation; autophagy; AMYLOID PRECURSOR PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NRF2 NUCLEAR TRANSLOCATION; ISCHEMIA-INDUCED APOPTOSIS; MONOAMINE OXIDASE-A; MAO-B INHIBITOR; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; OXIDATIVE STRESS;
D O I
10.2174/1570159X16666180419141613
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurodegenerative diseases are among the most serious health problems affecting millions of people worldwide. Such diseases are characterized by a progressive degeneration and / or death of neurons in the central nervous system. Currently, there are no therapeutic approaches to cure or even halt the progression of neurodegenerative diseases. During the last two decades, much attention has been paid to the neuroprotective and anti-neurodegenerative activities of compounds isolated from natural products with high efficacy and low toxicity. Accumulating evidence indicates that berberine, an isoquinoline alkaloid isolated from traditional Chinese medicinal herbs, may act as a promising anti-neurodegenerative agent by inhibiting the activity of the most important pathogenic enzymes, ameliorating intracellular oxidative stress, attenuating neuroinflammation, triggering autophagy and protecting neurons against apoptotic cell death. This review attempts to summarize the current state of knowledge regarding the therapeutic potential of berberine against neurodegenerative diseases, with a focus on the molecular mechanisms that underlie its effects on Alzheimer's, Parkinson's and Huntington's diseases.
引用
收藏
页码:563 / 579
页数:17
相关论文
共 271 条
[1]   In vitro biological assessment of berberis vulgaris and its active constituent, berberine: Antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects [J].
Abd El-Wahab A.E. ;
Ghareeb D.A. ;
Sarhan E.E.M. ;
Abu-Serie M.M. ;
El Demellawy M.A. .
BMC Complementary and Alternative Medicine, 13 (1)
[2]   Ameliorative effect of naringin in acetaminophen-induced hepatic and renal toxicity in laboratory rats: role of FXR and KIM-1 [J].
Adil, Mohammad ;
Kandhare, Amit D. ;
Ghosh, Pinaki ;
Venkata, Shivakumar ;
Raygude, Kiran S. ;
Bodhankar, Subhash L. .
RENAL FAILURE, 2016, 38 (06) :1007-1020
[3]   Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease [J].
Agis-Torres, Angel ;
Soellhuber, Monica ;
Fernandez, Maria ;
Sanchez-Montero, J. M. .
CURRENT NEUROPHARMACOLOGY, 2014, 12 (01) :2-36
[4]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[5]   The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
Albert, Marilyn S. ;
DeKosky, Steven T. ;
Dickson, Dennis ;
Dubois, Bruno ;
Feldman, Howard H. ;
Fox, Nick C. ;
Gamst, Anthony ;
Holtzman, David M. ;
Jagust, William J. ;
Petersen, Ronald C. ;
Snyder, Peter J. ;
Carrillo, Maria C. ;
Thies, Bill ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :270-279
[6]  
Alzheimers Association, 2017, Alzheimer's Dementia, V13, P325, DOI [10.1016/j.jalz.2017.02.001, DOI 10.1016/J.JALZ.2017.02.001]
[7]  
Amritpal Singh Amritpal Singh, 2010, Journal of Natural Products (India), V3, P64
[8]   The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment [J].
An, Yuan ;
Sun, Zhuangzhuang ;
Zhang, Yajuan ;
Liu, Bin ;
Guan, Yuanyuan ;
Lu, Meisong .
CLINICAL ENDOCRINOLOGY, 2014, 80 (03) :425-431
[9]   Therapeutics of Alzheimer's disease: Past, present and future [J].
Anand, R. ;
Gill, Kiran Dip ;
Mahdi, Abbas Ali .
NEUROPHARMACOLOGY, 2014, 76 :27-50
[10]   THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].
ANDREW, SE ;
GOLDBERG, YP ;
KREMER, B ;
TELENIUS, H ;
THEILMANN, J ;
ADAM, S ;
STARR, E ;
SQUITIERI, F ;
LIN, BY ;
KALCHMAN, MA ;
GRAHAM, RK ;
HAYDEN, MR .
NATURE GENETICS, 1993, 4 (04) :398-403